We are currently in pre-clinical development of the islet sheet with our collaborators at the University of California, Irvine. Upon completion of a pre-clinical development and receiving an Investigational New Drug Approval (INDA) from the FDA, Cerco Medical shall commence clinical trials in accordance with a protocal approved by the FDA. Participation shall be subject to such protocol.